Ph.D. candidate at the Indian Institute of Technology Madras, Chennai (India).
Had been awarded a two-year fellowship from Loyola University, USA and University of Cincinnati, USA to work on the “Pathological consequences of cMyBP-ΔC10 mutation at the single-cell level using hiPSC-derived cardiomyocytes” towards my Ph.D. thesis (Sep 2015-July 2017).
Stem Cell banking:
Have been trained & have gained tremendous skills in handling "Isolation, expansion & cryopreservation of clinical grade human adult stem cells (MSC) which could be potentially used for therapy". Haematopoietic stem cell banking-Isolation, cryopreservation & functional assay performance. Experienced in collection of umbilical cord blood & umbilical cord tissue
Immunotherapy for Glioblastoma multiforme using dendritic cells:
Glioblastoma multiforme (WHO grade IV astrocytoma), a deadly form of brain cancer is the most prevalent form of malignant primary brain tumor in humans. Treatment of patients with this medical condition remains a challenge with a median survival of 14.6 months, following diagnosis. Standard treatment options include surgery, radiation therapy and systemic chemotherapy. Recent advancements in immunotherapy have been considered the fourth modality suggesting an immunological and clinical response. My research studies focused on making a dendritic cell using the patients autologous peripheral blood monocytes and optimizing the introduction of tumor lysate proteins into these dendritic cells. These in vitro derived dendritic cell vaccines can be potentially used as an immunotherapy modality of treatment for Glioblastoma multiforme patients.